The new drug is a follow-up to Remicade, which is marketed in the United States by Johnson & Johnson and in Europe and in other countries by the Schering-Plough Corporation.
By THE ASSOCIATED PRESS, NY Times: Politics
Fri, 04/24/2009 - 4:59pm
The new drug is a follow-up to Remicade, which is marketed in the United States by Johnson & Johnson and in Europe and in other countries by the Schering-Plough Corporation.